AstraZeneca antibody injection able to prevent and treat Covid-19

11 October 2021

A trial led by Professor Hugh Montgomery (UCL Division of Medicine) has found that a new injection developed by AstraZeneca can reduce the risk of severe disease or death by 50% if given soon after people with a high risk of severe outcomes develop Covid-19 symptoms.